A Review of Theranostics Applications and Toxicities of Carbon Nanomaterials.

Abstract:

BACKGROUND:In the last few years, the use of modified Carbon Nanomaterials (CNMs) for theranostics (therapeutic and diagnosis) applications is a new and rapidly growing area in pharmacy and medical fields. Owing to this, their specific physicochemical behaviors like high stability, drug loading, surface area to volume ratio, with low toxicity and immunogenicity are mainly responsible to be considered those as smart nanomaterials. OBJECTIVES:This review describes the different dimensions of carbon-based nanocarriers including 0-D fullerene, 1-D Carbon Nanotubes (CNTs), and 2-D graphene and Graphene Oxide (GO) and their surface modification with different biocompatible and biodegradable molecules via covalent or non-covalent functionalization. The major focus of this article is on the different theranostics applications of CNMs like targeted drugs and genes delivery, photodynamic therapy, photothermal therapy, bioimaging, and biosensing. The therapeutic efficacy of drugs could be enhanced by delivering them directly on a specific site using different targeted ligands such as vitamins, peptide, carbohydrates, proteins, etc. A section of the article also discusses the toxicity of the CNMs to the living systems. CONCLUSIONS:In brief, this review article discusses the numerous theranostics applications and toxicities of CNMs.

journal_name

Curr Drug Metab

journal_title

Current drug metabolism

authors

Gupta N,Rai DB,Jangid AK,Kulhari H

doi

10.2174/1389200219666180925094515

subject

Has Abstract

pub_date

2019-01-01 00:00:00

pages

506-532

issue

6

eissn

1389-2002

issn

1875-5453

pii

CDM-EPUB-93198

journal_volume

20

pub_type

杂志文章,评审
  • Drug-induced Cholestasis: Mechanisms, Models, and Markers.

    abstract:BACKGROUND:Drug-induced cholestasis is a risk factor in the progression of drug candidates, and poses a serious health hazard if not detected before going into a human. Intrahepatic accumulation of Bile Acids (BAs) represents a characteristic phenomenon associated with drug-induced cholestasis. METHODS:This review wil...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180427165035

    authors: Chatterjee S,Annaert P

    更新日期:2018-01-01 00:00:00

  • Strong Association between Serotonin Transporter 5-HTTVNTR Variant and Psychoactive Substance (Nicotine) Use in the Turkish Cypriot Population.

    abstract:BACKGROUND:The use of psychoactive substances is one of the most dangerous social problems worldwide. Nicotine dependence results from the interaction between neurobiological, environmental and genetic factors. Serotonin is a neurotransmitter that has a wide range of central nervous system activities. The serotonin tra...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200221666200620201348

    authors: Kandemis E,Tuncel G,Asut O,Temel SG,Ergoren MC

    更新日期:2020-01-01 00:00:00

  • Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.

    abstract::Brain, the centre of the nervous system and an integral part the body, is protected by two anatomical and physiological barriers- Blood-Brain Barrier (BBB) and Blood-Cerebrospinal Fluid Barrier (BCSFB). Blood-Brain Barrier is a very complex and highly organized multicellular structure that shields the brain from harmf...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200218666170113125132

    authors: Sarkar A,Fatima I,Jamal QMS,Sayeed U,Khan MKA,Akhtar S,Kamal MA,Farooqui A,Siddiqui MH

    更新日期:2017-01-01 00:00:00

  • Liver-based in vitro technologies for drug biotransformation studies - a review.

    abstract::Early understanding of the metabolic pathway and potential interaction of new drug candidates with other drugs is one of the goals of preclinical studies in the drug discovery process. Although other body organs are involved in drug biotransformation, the liver is the predominant organ of metabolism for a wide range o...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920012798918426

    authors: Fasinu P,Bouic PJ,Rosenkranz B

    更新日期:2012-02-01 00:00:00

  • Species-specific and age-dependent bile acid composition: aspects on CYP8B and CYP4A subfamilies in bile acid biosynthesis.

    abstract::The present review aims to give an overview of the cytochrome P450 8B (CYP8B) and cytochrome P450 4A (CYP4A) subfamilies in relation to biosynthesis of bile acids, in particular trihydroxy bile acids. Trihydroxy bile acids are basically required in most species and have an impact on cholesterol and lipid metabolism. T...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920008784220574

    authors: Lundell K,Wikvall K

    更新日期:2008-05-01 00:00:00

  • Has the Time Come to Employ Population and Individual Bioequivalence for the Evaluation of Generics?

    abstract:BACKGROUND:Bioequivalence studies are a vital part of drug development. The average bioequivalence approach is the standard method of assessment to conclude whether the generic product is bioequivalent to the innovator product. Of late, debates are on whether the average bioequivalence approach adequately addresses dru...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,随机对照试验

    doi:10.2174/1389200221666200401105119

    authors: Micheal F,Sayana M,Prasad R,Motilal BM

    更新日期:2020-01-01 00:00:00

  • Decreasing systemic toxicity via transdermal delivery of anticancer drugs.

    abstract::When used at a high dose, many anticancer drugs produce undesirable side effects including hepatotoxicity. Transdermal delivery bypasses first-pass metabolism, allowing the use of a lower dose of drug while decreasing systemic toxicity. In this review, we summarize various advanced technologies for improving anticance...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920008785821693

    authors: Fang JY,Liu PF,Huang CM

    更新日期:2008-09-01 00:00:00

  • Prediction of human drug metabolizing enzyme induction.

    abstract::New chemical entities are routinely screened in vitro and in vivo for their ability to induce cytochrome P450s (CYP), other drug-metabolizing enzymes and possibly transporters in an attempt to more accurately predict clinical parameters such as drug-drug interactions and clearance in humans. Some of these potential th...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200033489352

    authors: Mankowski DC,Ekins S

    更新日期:2003-10-01 00:00:00

  • Gender differences in p-glycoprotein expression and function: effects on drug disposition and outcome.

    abstract::Gender differences in drug concentrations, drug response and toxicity have been attributed to various distinct yet interrelated physiological and molecular mechanisms. Drug transporters and metabolising enzymes play an important role in the xenobiotic cascade and are important regulators of drug disposition at the mol...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920009788498996

    authors: Bebawy M,Chetty M

    更新日期:2009-05-01 00:00:00

  • Significance of Pharmacogenetics and Pharmacogenomics Research in Current Medical Practice.

    abstract::Human genome sequencing highlights the involvement of genetic variation towards differential risk of human diseases, presence of different phenotypes, and response to pharmacological elements. This brings the field of personalized medicine to forefront in the era of modern health care. Numerous recent approaches have ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200217666160804150959

    authors: Prakash S,Agrawal S

    更新日期:2016-01-01 00:00:00

  • Effects of culture duration on gene expression of P450 isoforms, uptake and efflux transporters in primary hepatocytes cultured in the absence and presence of interleukin-6: implications for experimental design for the evaluation of downregulatory effects

    abstract::We report here a comprehensive evaluation of the effects of culture duration on the gene expression of P450 isoforms, uptake transporters and efflux transporters in human hepatocyte cultured in the absence and presence of the prototypical proinflammatory cytokine, interleukin-6 (IL-6). Primary collagen-matrigel sandwi...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920012802138570

    authors: Yang Q,Doshi U,Li N,Li AP

    更新日期:2012-09-01 00:00:00

  • Characterization of an etoposide-glutathione conjugate derived from metabolic activation by human cytochrome p450.

    abstract::Etoposide (VP-16), a DNA topoisomerase II poison widely used as an antineoplastic agent is also known to cause leukemia. One of its major metabolic pathways involves O-demethylation to etoposide catechol (etoposide-OH) by cytochrome P450 3A4 (CYP3A4). The catechol metabolite can undergo sequential one- and two-electro...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920006779010638

    authors: Zheng N,Pang S,Oe T,Felix CA,Wehrli S,Blair IA

    更新日期:2006-12-01 00:00:00

  • Polymer-based cancer nanotheranostics: retrospectives of multi-functionalities and pharmacokinetics.

    abstract::The pressing need for targeting, detecting, monitoring, and treating diseased cells concomitantly gives rise to multi-functional nanomedicines, especially those that can combine diagnostic and therapeutic abilities, which are referred to as nanotheranostics. Recently, nanotheranostics are of significant clinical inter...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200211314060003

    authors: Han N,Yang YY,Wang S,Zheng S,Fan W

    更新日期:2013-07-01 00:00:00

  • Safety and tolerability of agomelatine: focus on hepatotoxicity.

    abstract::Hepatotoxicity related to antidepressive pharmacotherapy is a major safety concern, particularly considering that severe forms of hepatic failure with fatal outcome have been reported. Severe hepatotoxic adverse drug reactions were also reported for agomelatine (AGM), an antidepressive agent, which was approved for th...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200215666140926155041

    authors: Gahr M,Kratzer W,Fuchs M,Connemann BJ

    更新日期:2014-01-01 00:00:00

  • The Effects of Genetic Polymorphisms in Pharmacokinetics and Pharmacodynamics Parameters.

    abstract:: ...

    journal_title:Current drug metabolism

    pub_type: 社论

    doi:10.2174/138920021914181211113837

    authors: Wei JF

    更新日期:2018-01-01 00:00:00

  • Cholinesterase reactivators: the fate and effects in the organism poisoned with organophosphates/nerve agents.

    abstract::Understanding the mechanism of action of organophosphates (OP)/nerve agents -- irreversible acetylcholinesterase (AChE, EC 3.1.1.7) inhibition at the cholinergic synapses followed by metabolic dysbalance of the organism -- two therapeutic principles for antidotal treatment are derived. The main drugs are anticholinerg...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920007782798144

    authors: Bajgar J,Kuca K,Jun D,Bartosova L,Fusek J

    更新日期:2007-12-01 00:00:00

  • The impact of in vitro binding on in vitro-in vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactions.

    abstract::This review provides a vista of the current opportunities and remaining challenges in the area of in vitro-in vivo extrapolation, with particular emphasis on drug binding terms in predictive models, which has been the source of much controversy. Although the importance of fu(inc) (fraction unbound in in vitro incubati...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920006776359266

    authors: Grime K,Riley RJ

    更新日期:2006-04-01 00:00:00

  • Kidney-on-a-Chip: A New Technology for Predicting Drug Efficacy, Interactions, and Drug-induced Nephrotoxicity.

    abstract:BACKGROUND:Kidney dysfunction resulting from various drugs is an important issue during the drug development process. Traditional in vivo animal experiments are limited with respect to evaluating drug efficacy and nephrotoxicity due to discrepancies in drug pharmacokinetics and pharmacodynamics between humans and anima...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180309101844

    authors: Lee J,Kim S

    更新日期:2018-01-01 00:00:00

  • Recent Developments of Magnetic Nanoparticles for Theranostics of Brain Tumor.

    abstract:BACKGROUND:Glioblastoma multiforme, one of the most aggressive brain tumors, has a very poor clinical outcome. Despite the introduction of the alkylating reagent temozolomide (TMZ) to surgery and radiotherapy, the survival of patients could only be modestly increased up to less than 15 months. Therefore, innovative tre...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200217666160607232540

    authors: Shevtsov M,Multhoff G

    更新日期:2016-01-01 00:00:00

  • Tubular and Glomerular Biomarkers of Acute Kidney Injury in Newborns.

    abstract:BACKGROUND:Acute Kidney Injury (AKI) is a sudden decrease in kidney function. In the early period, the highest percentage of AKI occurs among newborns hospitalized in the neonatal intensive care units, especially premature neonates. The prognosis of AKI depends on the type and severity of the cause of an injury, the ac...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200220666190321142417

    authors: Kamianowska M,Szczepański M,Wasilewska A

    更新日期:2019-01-01 00:00:00

  • Transcriptome and proteome analyses of drug interactions with natural products.

    abstract::Advances in high-throughput technologies to measure genome-scale changes of genes, proteins, and other biomolecular components ('omics') in complex biological systems have dramatically revolutionized biomedical research. However, the benefits of utilizing omics information in drug development have not yet been fully r...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920008786927802

    authors: Fang H,Wang K,Zhang J

    更新日期:2008-12-01 00:00:00

  • Optimization of Drugs Pharmacotherapy During Pregnancy Using Physiologically Based Pharmacokinetic Models - An Update.

    abstract:BACKGROUND:Clinical studies during pregnancy are rare due to ethical and practical limitations. Giving pregnant females the same dosing regimen used in adult males or nonpregnant females is inappropriate. Pregnancy physiologically-based pharmacokinetic modeling is a powerful tool that can be used to refine pharmacother...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180702104034

    authors: Alsmadi MM,Idkaidek N

    更新日期:2018-01-01 00:00:00

  • Complexities of glucuronidation affecting in vitro in vivo extrapolation.

    abstract::Glucuronidation is responsible for the clearance of a diverse range of drug and chemicals whose topology confers properties that complicate in vitro-in vivo clearance correlations as compared to those possible for oxidative metabolism. The active site of the UGTs faces the inside of the luminal space of the endoplasmi...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200023336992

    authors: Lin JH,Wong BK

    更新日期:2002-12-01 00:00:00

  • Curcumin - A Novel Therapeutic Agent in the Prevention of Colorectal Cancer.

    abstract:BACKGROUND:Colorectal cancer is the third important cause of cancer-associated deaths across the world. Hence, there is an urgent need for understanding the complete mechanism associated with colorectal cancer, which in turn can be utilized toward early detection as well as the treatment of colorectal cancer in humans....

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200220666191007153238

    authors: Gupta MK,Vadde R,Sarojamma V

    更新日期:2019-01-01 00:00:00

  • Pharmacokinetics, Metabolism, Distribution and Permeability of Nanomedicine.

    abstract:BACKGROUND:Medical application of nanotechnology is termed as Nanomedicine and is widely used in healthcare industries. Nanotechnology has helped Physicians, Scientists and Technologists to understand the changes in cellular levels to develop nanomedicines and address the challenges faced by the healthcare sectors. Nan...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180305154119

    authors: Ravindran S,Suthar JK,Rokade R,Deshpande P,Singh P,Pratinidhi A,Khambadkhar R,Utekar S

    更新日期:2018-01-01 00:00:00

  • Clinical utility of acarbose, an alpha-glucosidase inhibitor in cardiometabolic disorders.

    abstract::Diabetes is associated with an increase risk for cardiovascular disease (CVD). Recently, macrovascular complications of diabetes have been shown to start before the development of diabetes. Indeed, several clinical studies have confirmed the increased risk of CVD in patients with impaired glucose tolerance (IGT). Sinc...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920009787522133

    authors: Yamagishi S,Matsui T,Ueda S,Fukami K,Okuda S

    更新日期:2009-02-01 00:00:00

  • Atypical antipsychotic metabolism and excretion.

    abstract:BACKGROUND:The metabolic/biotransformation pathways of atypical antipsychotics (aripiprazole, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) have been characterized and reviewed. However, comparisons of excretory pathways remain unexplored. OBJECTIVE:To analyze the excretio...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920010791636202

    authors: Sheehan JJ,Sliwa JK,Amatniek JC,Grinspan A,Canuso CM

    更新日期:2010-07-01 00:00:00

  • Reaction phenotyping in drug discovery: moving forward with confidence?

    abstract::For the pharmaceutical industry, one of the challenges in evaluating the risk of future compound attrition at the discovery stage is the successful prediction of the major routes of clearance in humans. For compounds cleared by metabolism, such information will help to avoid the development of compounds that will exhi...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200033489235

    authors: Williams JA,Hurst SI,Bauman J,Jones BC,Hyland R,Gibbs JP,Obach RS,Ball SE

    更新日期:2003-12-01 00:00:00

  • Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs.

    abstract::Ophthalmic drugs are delivered to ocular tissues predominantly via relatively simple formulations, such as topically dosed water-soluble drug solutions and water-insoluble drug suspensions in ointments. An ideal topical drug delivery system should possess certain desirable properties, such as good corneal and conjunct...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920007779815977

    authors: Bu HZ,Gukasyan HJ,Goulet L,Lou XJ,Xiang C,Koudriakova T

    更新日期:2007-02-01 00:00:00

  • Hepatotoxicity and tumorigenicity induced by metabolic activation of pyrrolizidine alkaloids in herbs.

    abstract::In the recent decades, the use of herbal products has been rapidly growing in the Western countries. While their use in many cases causes adverse effects, to date, safety issues of herbal products have not been adequately addressed. It is rarely determined whether the non-purported bioactive constituents in the herbs ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920011797470119

    authors: Li N,Xia Q,Ruan J,Fu PP,Lin G

    更新日期:2011-11-01 00:00:00